Detalhe da pesquisa
1.
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Mol Cancer
; 15(1): 63, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756406
2.
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Cancers (Basel)
; 13(5)2021 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800365
3.
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience.
JCO Precis Oncol
; 22018.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913998
4.
ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Oncotarget
; 8(10): 17164-17190, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199979
5.
Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.
Am J Cancer Res
; 6(3): 664-76, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27152243
6.
Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas.
Virchows Arch
; 466(5): 503-15, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680570